A cholinergic interaction in alpha 2 adrenoceptor-mediated antinociception in sheep

Area of Science:

• Neuroscience
• Pharmacology
• Anesthesiology

Background:

• Alpha 2 adrenergic agonists administered intraspinally can produce analgesia.
• Clinical use is limited by dose-dependent sedation and hypotension.
• Neostigmine has shown potential to mitigate these side effects and enhance antinociception.

Purpose of the Study:

• To investigate the spinal interaction between alpha 2 adrenergic agonists and cholinergic mechanisms in analgesia.
• To evaluate the role of neostigmine and lipid solubility in the antinociceptive effects of alpha 2 adrenergic agonists.

Main Methods:

• Conscious sheep with chronic preparations were used to test antinociception via mechanical pressure stimulus.
• Effects of clonidine, idazoxan, methylatropine, and neostigmine on antinociception and acetylcholine levels were assessed.
• Lipid solubility of alpha 2 adrenergic agonists (dexmedetomidine, clonidine, ST-91) was correlated with their antinociceptive efficacy and effect on acetylcholine.

Main Results:

• Clonidine produced dose-dependent antinociception, enhanced by neostigmine and antagonized by idazoxan.
• Clonidine increased spinal acetylcholine, an effect potentiated by physostigmine and blocked by idazoxan.
• Highly lipid-soluble agonists (dexmedetomidine, clonidine) were effective, while poorly lipid-soluble ST-91 required higher doses and did not affect acetylcholine.

Conclusions:

• Evidence supports an interaction between spinal alpha 2 adrenergic and cholinergic pathways for analgesia.
• Neostigmine enhances antinociception and counteracts hypotension associated with alpha 2 adrenergic agonists.
• Lipid solubility is crucial for the efficacy of spinally administered alpha 2 adrenergic agonists in sheep.